Brian Millham - 08 Aug 2022 Form 3 Insider Report for Salesforce, Inc. (CRM)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
17 Aug 2022, 19:07:15 UTC
Next SEC filing
26 Sep 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Scott Siamas, Attorney-in-Fact for Brian Millham

Key filing fact

Brian Millham filed Form 3 for Salesforce, Inc. (CRM) on 17 Aug 2022.

Key facts

  • This page summarizes Brian Millham's Form 3 filing for Salesforce, Inc. (CRM).
  • 0 reported transactions and 12 derivative rows are listed below.
  • Accepted by SEC: 17 Aug 2022, 19:07.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,723
Date
08 Aug 2022
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRM holding Derivative

Non-qualified Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,218
Exercise price
$118.04
Footnotes
F1
CRM holding Derivative

Non-qualified Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,608
Exercise price
$146.87
Footnotes
F2
CRM holding Derivative

Non-qualified Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,362
Exercise price
$161.50
Footnotes
F3
CRM holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
922
Exercise price
$0.000000
Footnotes
F4, F5
CRM holding Derivative

Non-qualified Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
54,110
Exercise price
$154.14
Footnotes
F6
CRM holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,583
Exercise price
$0.000000
Footnotes
F5, F7
CRM holding Derivative

Non-qualified Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
415,009
Exercise price
$240.95
Footnotes
F8
CRM holding Derivative

Non-qualified Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
96,855
Exercise price
$215.17
Footnotes
F9
CRM holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
17,980
Exercise price
$0.000000
Footnotes
F5, F10
CRM holding Derivative

Non-qualified Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
101,121
Exercise price
$218.21
Footnotes
F11
CRM holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
27,303
Exercise price
$0.000000
Footnotes
F5, F12
CRM holding Derivative

Performance-Based Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Aug 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,592
Exercise price
$0.000000
Footnotes
F13, F14
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 14 footnotes

Footnote F1

Option is exercisable and vests over four years at the rate of 25% on March 22, 2019, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

Footnote F2

Option is exercisable and vests over four years at the rate of 25% on July 22, 2019, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

Footnote F3

Option is exercisable and vests over four years at the rate of 25% on March 22, 2020, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

Footnote F4

These restricted stock units vest as to 25% of the original grant on March 22, 2020 and vest as to 1/16 of the original grant quarterly thereafter.

Footnote F5

Restricted stock units convert to shares of Issuer common stock on a one-for-one basis.

Footnote F6

Option is exercisable and vests over four years at the rate of 25% on April 22, 2021, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

Footnote F7

These restricted stock units vest as to 25% of the original grant on April 22, 2021, and vest as to 1/16 of the original grant quarterly thereafter.

Footnote F8

Option is exercisable and vests over four years at the rate of 25% on February 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

Footnote F9

Option is exercisable and vests over four years at the rate of 25% on March 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

Footnote F10

These restricted stock units vest as to 25% of the original grant on March 22, 2022, and vest as to 1/16 of the original grant quarterly thereafter.

Footnote F11

Option is exercisable and vests over four years at the rate of 25% on March 22, 2023, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

Footnote F12

These restricted stock units vest as to 25% of the original grant on March 22, 2023, and vest as to 1/16 of the original grant quarterly thereafter.

Footnote F13

The PRSUs will vest depending on Issuer's total shareholder return ("TSR") over the three-year period from the grant date (the "Performance Period"), relative to companies in the NASDAQ-100 Index as of the grant date (the "Index Group"). If Issuer's TSR over the Performance Period is at the 60th percentile when ranked against the Index Group TSRs, 100% of the target number of shares will vest. For every percentile by which Issuer's TSR ranking within the Index Group exceeds the 60th percentile, shares vesting will increase by 3 and 1/3%, up to a maximum payout of 200% of target if Issuer's TSR ranking is at the 99th percentile. For every percentile by which Issuer's TSR ranking within the Index Group is below the 60th percentile, shares vesting will decrease by 2 and 22/39%, with no payout if Issuer's TSR ranking is below the 30th percentile. If Issuer's absolute TSR over the Performance Period is negative, the number of shares vesting will not exceed 100% of target.

Footnote F14

Each performance-based restricted stock unit, or PRSU, represents a contingent right to receive one share of Issuer common stock.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .